Relation between indices of end-organ damage and mean platelet volume in hypertensive patients

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 5, 2012, Pages 367-369

  Bulur, Serkan ^a   Önder, Halil Ibrahim ^b   Aslantas, Yusuf ^a   Ekinozu, Ismail ^a   Kiliç, Aliçaǧr ^b   Yalcin, Sübhan ^a   Bulur, Şule ^c   Ozhan, Hakan ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

^c SELCUK UNIVERSITY   (Turkey)

Author keywords

end organ damage; hypertension; mean platelet volume

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; END ORGAN DAMAGE; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; ORGAN INJURY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; THROMBOCYTE VOLUME; URINALYSIS;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PRESSURE; CELL SIZE; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTENSIVE RETINOPATHY; MALE; MIDDLE AGED; PLATELET COUNT; RISK FACTORS;

EID: 84863333307     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835291b1     Document Type: Article

References (12)

1. Schmieder RE. End organ damage in hypertension. Dtsch Arztebl Int 2010; 107:866-873; Revie.w.
2. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25:2184.
3. Yarlioglues M, Kaya MG, Ardic I, Dogdu O, Kasapkara HA, Gunturk E, et al. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 2011; 20:92-97.
4. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, et al. Platelet activation and inflammatory response in patients with nondipper hypertension. Atherosclerosis 2010; 209:278-282.
5. El Haouari M, Rosado JA. Platelets function in hypertension. Blood Cells Mol Dis 2009; 42:38-43.
6. Gabbasov Z, Parfyonova Y, Popov E, Gavrilov I, Anuchin V, Dubov P, et al. Association of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease. Platelets 1998; 9:191-195. (Pubitemid 28312678)
7. Scuteri A, Cacciafesta M, de Propris AM, di Bernardo MG, Recchi D, Celli V, et al. Platelet size and left ventricular hypertrophy in hypertensive patients over 50 years of age. Eur J Clin Invest 1995; 25:874-876.
8. Lip GY, Blann AD. Associations of platelet function in hypertensive patients with left ventricular hypertrophy. Platelets 1999; 10:71-72. (Pubitemid 29084390)
9. Guagnano MT, Ferroni P, Santilli F, Paoletti V, Manigrasso MR, Pescara L, et al. Determinants of platelet activation in hypertensives with microalbuminuria. Free Radic Biol Med 2009; 46:922-927.
10. Ferroni P, Guagnano MT, Falco A, Paoletti V, Manigrasso MR, Michetti N, et al. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci (Lond) 2008; 114:449-455. (Pubitemid 351397394)
11. van der Planken MG, Vertessen FJ, Vertommen J, Engelen W, Berneman ZN, De Leeuw I. Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy. Clin Appl Thromb Hemost 2000; 6:65-68. (Pubitemid 30230625)
12. Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets 2008; 19:115-118. (Pubitemid 351302379)